Morison Industries Plc (MORISN.ng) listed on the Nigerian Stock Exchange under the Chemicals sector has released it’s 2018 abridged results.For more information about Morison Industries Plc (MORISN.ng) reports, abridged reports, interim earnings results and earnings presentations, visit the Morison Industries Plc (MORISN.ng) company page on AfricanFinancials.Document: Morison Industries Plc (MORISN.ng) 2018 abridged results.Company ProfileMorison Industries Plc manufactures and markets a range of pharmaceutical and hygiene products in Nigeria as well as imports and distributes medical, surgical and hospital consumables. The company is a leader in the field of Woundcare solutions, trauma/arthroplasty and bone graft products in Nigeria. Its Advance Wound Management business offers a range of products from initial wound bed preparation to full wound closure. Antiseptics and disinfectants are marketed under the Morigad brand name. Other well known brands include Gypsona, Dynacast, Soffban, Cutisoft and Leukomed. Morison Industries Plc is involved in merchandising hip, knee and shoulder joints implants as well as ancillary products such as bone cement and biomaterials for elective orthopaedic and trauma surgery; and is a distributor of the full range of Braun medical products. Morison Agro Allied is a subsidiary of Morison Industries Plc and markets a range of agricultural preparations including herbicides and biocide disinfectants under the brand names Glutacide, Germicide and Lysol. Morison Industries Plc has an export license from the Nigerian Exportation Promotion Council to export shea nuts, cashew nuts, cocoa, ginger, bitter kola and sesame seeds. The company also has a division which manufactures and markets products made from fish oil with High Omega 3 content in addition to selling lifestyle products which improve blood pressure and cholesterol levels and helps reduce the risk of heart disease and strokes. The company’s head office is in Lagos, Nigeria. Morison Industries Plc is listed on the Nigerian Stock Exchange
Pfizer Inc and the Dalian Municipal Yang "Pfizer Dalian computer network domain name IP recently the dust settles, the Dalian City Intermediate People’s court verdict in favor of the Pfizer Inc, before the day of judgment has taken legal effect.
July 21, 2006, who lives in Dalian Wafangdian City, Ms. Yang was neteon Tech (Beijing) Co., Ltd. to apply for registration of the "computer network domain name Pfizer Dalian".
Pfizer Inc that Ms. Yang without the permission of the plaintiff, registered the "Pfizer Dalian" domain name, constitute an infringement of the plaintiff, then sued the Dalian City Intermediate People’s court, the request shall identify "Pfizer" for the well-known trademark, the defendant was ordered to immediately stop using and cancellation of "Pfizer Dalian" domain name for compensation to the plaintiff; the investigation of this case and the payment of attorney’s fees, 5000 yuan of economic losses.
defendant Yang argued that the domain name is registered in a legal way, should be protected by law, the plaintiff does not constitute infringement.
recently, the Dalian intermediate people’s court hearing the case. The court held that the focus of the two sides are: first, "Pfizer" trademark is a well-known trademark; two, whether the defendant constitutes a violation of the plaintiff’s trademark rights. According to the provisions of the relevant laws China, the people’s court in the trial involves computer network domain name of civil disputes, the parties based on the specific situation and consult the case, the trademark is well-known trademark cognizance. According to the relevant provisions of the trademark law, well-known trademark refers to the territory of our country is widely known for the relevant public and enjoy a high reputation of the trademark, etc.. In this case, the plaintiff is the "Pfizer" trademark registration rights, for a long time, the plaintiff’s products manufactured by Pfizer sales throughout the country, with a certain market share. The long time invested a lot of money on television, radio, newspapers and networks of Pfizer registered trademarks of publicity, and actively participate in public welfare undertakings, to enjoy a relatively high visibility and good reputation of the trademark in the consumer Chinese, widely recognized by the society, with a high reputation in the consumer, the trademark is in fact, to become well-known trademarks. The court upheld the plaintiff’s claim that Pfizer was a well-known trademark. According to the relevant provisions of the "Paris Convention", should be given a higher level of protection for the well-known trademark, because well-known trademark can bring greater commercial benefits to the obligee, without permission, the well-known trademark in any form for commercial use, will damage the policy for the protection of well-known trademark. In China, the protection of well-known trademarks is to prohibit the use of well-known trademarks as a domain name to engage in e-commerce activities. The defendant is not allowed by the plaintiff, the plaintiff trademark will be registered as their own domain name, it is easy to mislead the consumers, so that consumers believe that the domain name of the registrant and the plaintiff’s well-known trademark has some kind of connection, resulting in confusion. At the same time, because of the uniqueness of the Internet domain names, the registered "Pfizer Dalian" after the domain name, the plaintiff hinder the normal business through the use of the domain name on the Internet.